Stefan Oschmann (born 25 July 1957) is a German businessman. He was the CEO of pharma group Merck.

Stefan Oschmann
Born (1957-07-25) 25 July 1957 (age 67)
Würzburg, Germany
Alma materLMU (PhD in veterinary medicine, 1985)[1]
TitleChairman and CEO, Merck Group
TermApril 2016–April 2021

Biography

edit

Born in Würzburg, Germany,[1][2] Oschmann earned his doctorate in veterinary medicine from the Ludwig Maximilian University of Munich.[3] Oschmann started his career at an agency of the International Atomic Energy Agency.[3] In 1987, he started working for the German Animal Health Federation (Bundesverband für Tiergesundheit), the trade association for German manufacturers of veterinary drugs and feed additives.[1][4]

From 1989 to 2011, Oschmann worked for Merck Sharp & Dohme (MSD), the European operations of Merck & Co. He was managing director of MSD Austria from 1994, vice president for Central and Eastern Europe from 1998, vice president of MSD Europe and managing director of MSD Germany from 1999, senior vice president for worldwide human health marketing from 2005, president for Europe, the Middle East, Africa, and Canada from 2006 and finally MSD's president of emerging markets from 2009 to 2011.[5]

Oschmann joined the Merck Group as a member of the executive board in 2011. He was responsible for the healthcare business sector until the end of 2014.[6] He became vice chairman of the executive board and deputy CEO of the Merck Group in 2015. Oschmann became the chairman of the executive board and CEO of the Merck Group in April 2016, succeeding Karl-Ludwig Kley.[7][8][9][10] He stood down as Merck CEO at the end of April 2021.[11]

In May 2021, AiCuris AG announced the appointment of Oschmann as the new chair of its supervisory board.[12]

 
Oschmann during the MSC 2017

Other activities

edit

Corporate boards

edit
  • Allianz, Member of the Joint Advisory Board

Non-profit organizations

edit

Personal life

edit

Oschmann and his wife have two children.[3]

References

edit
  1. ^ a b c "2016 IFPMA General Assembly Biographies" (PDF). IFPMA. p. 4. Archived from the original (PDF) on 22 June 2017.
  2. ^ "Stefan Oschmann". DLD Conference. Retrieved 1 April 2018.
  3. ^ a b c GmbH, Echo Zeitungen. "Zur Person: Stefan Oschmann". Retrieved 2017-06-01.
  4. ^ "Bundesverband für Tiergesundheit" (in German). Vet Magazin. Retrieved 22 June 2017.
  5. ^ "Stefan Oschmann | Big Think". bigthink.com. Retrieved 9 September 2016.
  6. ^ "Merck-Chef Stefan Oschmann über den Kampf gegen den Krebs und die Konkurrenz von Google". DER SPIEGEL. Retrieved 2017-06-01.
  7. ^ Divac, Natascha (13 October 2015). "Germany's Merck Names New CEO". WSJ. Retrieved 14 October 2015.
  8. ^ Merck promotes Oschmann as CEO to replace Kley, The Financial Times, 13 October 2015
  9. ^ Germany, Merck KGaA, Darmstadt. "Stefan Oschmann - CV - The Merck Group". www.merckgroup.com. Retrieved 2017-05-04.{{cite web}}: CS1 maint: multiple names: authors list (link)
  10. ^ "Merck KGaA showing Teva the way?". Globes. 3 January 2018.
  11. ^ Lukas Heiny (2020-09-29). "Führungswechsel beim Pharmakonzern Zweite Chefin eines Dax-Konzerns – Belén Garijo wird im Mai neue CEO von Merck". Manager Magazin. Retrieved 2021-09-10.
  12. ^ "AiCuris AG Announces Dr. Stefan Oschmann, Former Merck CEO, to Chair the AiCuris Supervisory Board" (Press release). BioSpace. 25 May 2021. Retrieved 2021-09-10.
  13. ^ "EFPIA: Stefan Oschmann zum Präsidenten gewählt". CHEManager International (in German). 17 June 2017.
  14. ^ Board of Trustees Baden-Badener Unternehmer-Gespräche (BBUG).
  15. ^ Board of Trustees Deutsches Museum.
  16. ^ Members European Round Table of Industrialists.
  17. ^ "Vorstand & Präsidium - Verband der Chemischen Industrie e.V. (VCI)". www.vci.de (in German). Retrieved 2017-06-01.
  18. ^ Board of Trustees Max Planck Institute for Medical Research.
  19. ^ Advisory Council Munich Security Conference.
  20. ^ "Stefan Oschmann elected new President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) – IFPMA". www.ifpma.org. Retrieved 2017-06-01.
Business positions
Preceded by Chief Executive Officer, Merck Group
April 2016–April 2021
Succeeded by
Belén Garijo